GSK to unveil clinical trial results on several drugs in development

02/10/2005 | Wall Street Journal, The

GlaxoSmithKline plans to unveil today the results of clinical trials on several drugs, including one to treat diabetes, one of more than a dozen drugs the company has under development. The company has been overhauling its research and development division, and the progress on 13 drugs in Phase III trials out of about 90 products GSK is developing could be a positive response to investors who have been clamoring for results.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX